Cost-effectiveness analysis of reslizumab for patients with severe eosinophilic asthma inadequately controlled with high-dose inhaled corticosteroids and long-acting β2-agonists in South Korea

Author

Han S, Kim S, Kim H, and Suh HS

Journal

The International Society for Pharmacoeconomics and Outcomes Research 21st Annual European Congress

Remarks

Barcelona, Spain. November 2018.